Posted by Michael Wonder on 06 Nov 2025
Lilly and US Government agree to expand access to obesity medicines to millions of Americans
6 November 2025 - Eli Lilly today announced an agreement with the US Government to expand access to its obesity medicines and reduce patient costs.
The agreement builds on Lilly's longstanding commitment to finding solutions with policymakers that improve access to life-changing medicines. In 2020, Lilly partnered with the Trump Administration on a pilot program that paved the way for Lilly to be the first company to cap out of pocket insulin costs at $35/month. Lilly will now improve access to nearly 40 million Americans living with obesity on government insurance programs and millions more who pay out-of-pocket. Unlocking access to these medicines can be game changing for Americans with obesity – a risk factor driving more than 200 associated diseases, including heart disease, strokes and certain types of cancers.
